Impact of Aromatase Inhibitor Therapy on Glucose Homeostasis and Diabetes Risk
Impact of Aromatase Inhibitor Therapy on Glucose Homeostasis and Diabetes Risk
Recruiting · NCT06557057 · Registry updated 2026-09-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Impact of Aromatase Inhibitor Therapy on Glucose Homeostasis and Diabetes Risk | HER2-Positive Breast Carcinoma | Recruiting | Not stated | 2026-09-02 | NCT06557057 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Mayo Clinic | 970 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mayo Clinic in Rochester | Rochester | United States | 687 |